PEMBROLIZUMAB

PEMBROLIZUMAB was reported 108520 times

These side effects are most commonly reported by patients taking PEMBROLIZUMAB:

# Side effect Count
0 MALIGNANT NEOPLASM PROGRESSION 12384
1 DEATH 6043
2 DIARRHOEA 5920
3 FATIGUE 5236
4 OFF LABEL USE 4866
5 PYREXIA 4018
6 RASH 3883
7 NAUSEA 3672
8 PRODUCT USE IN UNAPPROVED INDICATION 3594
9 DECREASED APPETITE 3399
10 HYPERTENSION 3339
11 HYPOTHYROIDISM 3041
12 ASTHENIA 2865
13 DRUG INEFFECTIVE 2660
14 INTERSTITIAL LUNG DISEASE 2630
15 PRODUCT USE ISSUE 2622
16 ACUTE KIDNEY INJURY 2550
17 ANAEMIA 2514
18 MALAISE 2455
19 NEUTROPENIA 2450
20 DYSPNOEA 2418
21 VOMITING 2324
22 PNEUMONIA 2292
23 PNEUMONITIS 2271
24 NEUROPATHY PERIPHERAL 2221
25 COLITIS 2021
26 ARTHRALGIA 1973
27 THERAPY PARTIAL RESPONDER 1914
28 THROMBOCYTOPENIA 1884
29 WEIGHT DECREASED 1881
30 RENAL IMPAIRMENT 1879
31 PRURITUS 1825
32 PLATELET COUNT DECREASED 1757
33 ADRENAL INSUFFICIENCY 1670
34 FEBRILE NEUTROPENIA 1661
35 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1654
36 CONSTIPATION 1477
37 HEPATIC FUNCTION ABNORMAL 1400
38 PANCYTOPENIA 1399
39 PAIN 1389
40 HEADACHE 1381
41 ADVERSE EVENT 1353
42 MYOCARDITIS 1318
43 GENERAL PHYSICAL HEALTH DETERIORATION 1265
44 STOMATITIS 1225
45 BLOOD PRESSURE INCREASED 1216
46 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1197
47 ABDOMINAL PAIN 1177
48 COUGH 1156
49 IMMUNE-MEDIATED ENTEROCOLITIS 1153
50 DEHYDRATION 1135
51 HEPATITIS 1131
52 SEPSIS 1123
53 MYELOSUPPRESSION 1120
54 PROTEINURIA 1072
55 MYALGIA 1061
56 TUBULOINTERSTITIAL NEPHRITIS 1055
57 DISEASE PROGRESSION 1053
58 IMMUNE-MEDIATED HEPATIC DISORDER 1047
59 RENAL FAILURE 1031
60 PLEURAL EFFUSION 1021
61 HYPOTENSION 988
62 CARDIAC FAILURE 956
63 DYSPHONIA 955
64 NEUTROPHIL COUNT DECREASED 938
65 PULMONARY EMBOLISM 935
66 HYPERTHYROIDISM 928
67 DIZZINESS 899
68 HEPATIC CYTOLYSIS 893
69 IMMUNE-MEDIATED ADVERSE REACTION 893
70 URINARY TRACT INFECTION 877
71 RESPIRATORY FAILURE 857
72 ALANINE AMINOTRANSFERASE INCREASED 853
73 BACK PAIN 811
74 PAIN IN EXTREMITY 793
75 HYPONATRAEMIA 779
76 IMMUNE-MEDIATED MYOCARDITIS 779
77 ASPARTATE AMINOTRANSFERASE INCREASED 778
78 ERYTHEMA 778
79 CONDITION AGGRAVATED 731
80 DYSPHAGIA 731
81 IMMUNE-MEDIATED HEPATITIS 728
82 TYPE 1 DIABETES MELLITUS 727
83 MYOSITIS 711
84 NEOPLASM PROGRESSION 711
85 WHITE BLOOD CELL COUNT DECREASED 710
86 LEUKOPENIA 702
87 IMMUNE-MEDIATED HYPOTHYROIDISM 701
88 SKIN DISORDER 695
89 MUSCULAR WEAKNESS 688
90 IMMUNE-MEDIATED LUNG DISEASE 686
91 HEPATIC ENZYME INCREASED 679
92 NO ADVERSE EVENT 677
93 MUCOSAL INFLAMMATION 676
94 HEPATOTOXICITY 672
95 SEPTIC SHOCK 670
96 ALOPECIA 667
97 LIVER DISORDER 665
98 OEDEMA PERIPHERAL 659
99 BLOOD CREATININE INCREASED 647
100 INFECTION 645
101 THYROID DISORDER 634
102 DIABETES MELLITUS 623
103 TOXIC EPIDERMAL NECROLYSIS 621
104 TOXICITY TO VARIOUS AGENTS 618
105 DRY MOUTH 605
106 RASH MACULO-PAPULAR 605
107 THYROIDITIS 580
108 FALL 571
109 CONFUSIONAL STATE 569
110 ATRIAL FIBRILLATION 558
111 COVID-19 549
112 MYASTHENIA GRAVIS 549
113 CHEST PAIN 543
114 STEVENS-JOHNSON SYNDROME 543
115 GAIT DISTURBANCE 541
116 CHILLS 538
117 PANCREATITIS 538
118 C-REACTIVE PROTEIN INCREASED 536
119 LUNG DISORDER 536
120 ABDOMINAL PAIN UPPER 528
121 CYTOKINE RELEASE SYNDROME 526
122 PRODUCT DOSE OMISSION ISSUE 524
123 HYPOKALAEMIA 519
124 DRUG ERUPTION 515
125 ASCITES 503
126 DIABETIC KETOACIDOSIS 500
127 PERIPHERAL SWELLING 499
128 HYPOPHYSITIS 484
129 RASH PRURITIC 480
130 IMMUNE-MEDIATED DERMATITIS 478
131 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 477
132 TUMOUR PSEUDOPROGRESSION 475
133 SOMNOLENCE 471
134 MULTIPLE ORGAN DYSFUNCTION SYNDROME 469
135 HYPOAESTHESIA 465
136 HYPERGLYCAEMIA 464
137 NEPHRITIS 462
138 TASTE DISORDER 461
139 DRUG-INDUCED LIVER INJURY 459
140 CHOLANGITIS 455
141 HAEMOGLOBIN DECREASED 455
142 ARTHRITIS 447
143 ILL-DEFINED DISORDER 445
144 SEIZURE 443
145 INSOMNIA 441
146 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 439
147 CEREBROVASCULAR ACCIDENT 436
148 EPISTAXIS 435
149 PULMONARY TOXICITY 418
150 DRY SKIN 416
151 PERICARDIAL EFFUSION 411
152 FEELING ABNORMAL 409
153 GASTROINTESTINAL DISORDER 408
154 RHEUMATOID ARTHRITIS 406
155 SKIN TOXICITY 403
156 INFUSION RELATED REACTION 402
157 IMMUNE-MEDIATED MYOSITIS 400
158 BLISTER 399
159 BLOOD THYROID STIMULATING HORMONE INCREASED 396
160 CHOLESTASIS 395
161 ENCEPHALITIS 395
162 PEMPHIGOID 392
163 INCORRECT DOSE ADMINISTERED 389
164 PARAESTHESIA 386
165 MYOCARDIAL INFARCTION 382
166 LYMPHADENOPATHY 380
167 OEDEMA 380
168 AUTOIMMUNE HEPATITIS 376
169 CEREBRAL INFARCTION 372
170 LICHENOID KERATOSIS 372
171 WEIGHT INCREASED 365
172 ANXIETY 364
173 DEEP VEIN THROMBOSIS 360
174 TROPONIN INCREASED 357
175 THERAPY NON-RESPONDER 356
176 BLOOD GLUCOSE INCREASED 355
177 RADIOTHERAPY 353
178 RENAL TUBULAR NECROSIS 350
179 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 343
180 HEPATIC FAILURE 343
181 DRUG INTOLERANCE 339
182 PNEUMONIA ASPIRATION 337
183 URTICARIA 336
184 CARDIAC ARREST 333
185 BLOOD PRESSURE DECREASED 331
186 TACHYCARDIA 325
187 TRANSAMINASES INCREASED 323
188 PSORIASIS 321
189 ABDOMINAL DISCOMFORT 320
190 PNEUMOTHORAX 320
191 CHOLECYSTITIS 319
192 HYPOXIA 319
193 DRUG INTERACTION 313
194 HOSPITALISATION 313
195 GASTROINTESTINAL HAEMORRHAGE 310
196 RENAL DISORDER 309
197 HYPERSENSITIVITY 308
198 SKIN EXFOLIATION 306
199 BLOOD BILIRUBIN INCREASED 305
200 HAEMOPTYSIS 295
201 INTESTINAL PERFORATION 295
202 THROMBOSIS 294
203 DERMATITIS 292
204 HYPERTRANSAMINASAEMIA 291
205 TREMOR 289
206 DRUG HYPERSENSITIVITY 288
207 DYSGEUSIA 285
208 HAEMORRHAGE 285
209 MUSCLE SPASMS 285
210 INFLAMMATION 280
211 VISUAL IMPAIRMENT 279
212 ADVERSE DRUG REACTION 278
213 ERYTHEMA MULTIFORME 277
214 ENTEROCOLITIS 276
215 DYSPNOEA EXERTIONAL 275
216 VISION BLURRED 275
217 OXYGEN SATURATION DECREASED 272
218 DISSEMINATED INTRAVASCULAR COAGULATION 271
219 LOSS OF CONSCIOUSNESS 271
220 PNEUMONIA BACTERIAL 270
221 BONE PAIN 266
222 HAEMATURIA 264
223 IMMUNE-MEDIATED THYROIDITIS 263
224 FEBRILE BONE MARROW APLASIA 261
225 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 260
226 HYPERKALAEMIA 260
227 AGRANULOCYTOSIS 258
228 BLOOD CREATINE PHOSPHOKINASE INCREASED 257
229 IMMUNE-MEDIATED RENAL DISORDER 257
230 DYSPEPSIA 254
231 INTESTINAL OBSTRUCTION 254
232 LIVER FUNCTION TEST INCREASED 252
233 PNEUMOCYSTIS JIROVECII PNEUMONIA 252
234 DELIRIUM 249
235 FEEDING DISORDER 248
236 DERMATITIS BULLOUS 246
237 ALTERED STATE OF CONSCIOUSNESS 245
238 IMMUNE THROMBOCYTOPENIA 244
239 METASTASES TO CENTRAL NERVOUS SYSTEM 243
240 ECZEMA 242
241 SYNCOPE 242
242 CHEST DISCOMFORT 241
243 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 241
244 HYPOPHAGIA 241
245 ILLNESS 241
246 NEPHROPATHY TOXIC 241
247 PULMONARY OEDEMA 240
248 ENCEPHALOPATHY 239
249 MEMORY IMPAIRMENT 239
250 CELLULITIS 237
251 ACUTE RESPIRATORY FAILURE 236
252 ORAL PAIN 236
253 GASTRITIS 235
254 DEPRESSION 233
255 CEREBRAL HAEMORRHAGE 232
256 BALANCE DISORDER 231
257 COLITIS ULCERATIVE 231
258 ILEUS 231
259 HERPES ZOSTER 230
260 CARDIOMYOPATHY 229
261 HYPOPITUITARISM 229
262 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 229
263 OROPHARYNGEAL PAIN 228
264 HAEMATOTOXICITY 224
265 VITILIGO 224
266 RHABDOMYOLYSIS 223
267 BLOOD ALKALINE PHOSPHATASE INCREASED 222
268 CYTOPENIA 222
269 RASH ERYTHEMATOUS 222
270 PULMONARY MASS 220
271 BLOOD PRESSURE ABNORMAL 219
272 SURGERY 218
273 IMMUNE-MEDIATED ENCEPHALITIS 217
274 EJECTION FRACTION DECREASED 216
275 GAIT INABILITY 215
276 JOINT SWELLING 214
277 ABDOMINAL DISTENSION 213
278 BONE MARROW FAILURE 213
279 ACUTE MYOCARDIAL INFARCTION 208
280 GUILLAIN-BARRE SYNDROME 207
281 HYPOMAGNESAEMIA 205
282 GASTROINTESTINAL PERFORATION 204
283 TREATMENT FAILURE 204
284 EYELID PTOSIS 203
285 HAEMATOCHEZIA 202
286 EOSINOPHILIA 201
287 HEPATOCELLULAR INJURY 200
288 HEART RATE INCREASED 199
289 LARGE INTESTINE PERFORATION 198
290 WHITE BLOOD CELL COUNT INCREASED 198
291 ANAPHYLACTIC REACTION 197
292 GAMMA-GLUTAMYLTRANSFERASE INCREASED 197
293 CARDIO-RESPIRATORY ARREST 196
294 SECONDARY ADRENOCORTICAL INSUFFICIENCY 194
295 ADRENAL DISORDER 192
296 ARRHYTHMIA 192
297 DRY EYE 192
298 PALPITATIONS 192
299 SKIN REACTION 192
300 IMMUNE-MEDIATED HYPOPHYSITIS 191
301 HYPOTHALAMO-PITUITARY DISORDER 190
302 IMMUNE-MEDIATED NEPHRITIS 190
303 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 190
304 BLOOD SODIUM DECREASED 189
305 IMMUNE-MEDIATED PANCREATITIS 189
306 PRODUCTIVE COUGH 189
307 ENTERITIS 188
308 IMMUNE-MEDIATED ARTHRITIS 187
309 NASOPHARYNGITIS 187
310 COGNITIVE DISORDER 186
311 CARDIOTOXICITY 185
312 ORGANISING PNEUMONIA 184
313 POLYMYALGIA RHEUMATICA 184
314 CARDIAC DISORDER 183
315 ACUTE RESPIRATORY DISTRESS SYNDROME 182
316 HYPOCALCAEMIA 182
317 HOSPICE CARE 180
318 HYPERHIDROSIS 178
319 DIPLOPIA 177
320 LIVER INJURY 177
321 CHOLANGITIS SCLEROSING 176
322 DRUG RESISTANCE 176
323 DYSURIA 174
324 JAUNDICE 174
325 RESPIRATORY DISTRESS 174
326 CARDIOGENIC SHOCK 173
327 BLOOD PRESSURE FLUCTUATION 172
328 OESOPHAGITIS 172
329 PANCREATITIS ACUTE 172
330 SJOGREN^S SYNDROME 172
331 AGEUSIA 171
332 HYPERCALCAEMIA 170
333 MUSCULOSKELETAL PAIN 170
334 PYELONEPHRITIS 170
335 CORTISOL DECREASED 169
336 LETHARGY 169
337 POLYNEUROPATHY 168
338 SPEECH DISORDER 166
339 TUMOUR LYSIS SYNDROME 166
340 METASTASES TO BONE 165
341 MOVEMENT DISORDER 165
342 SWELLING 165
343 FLUSHING 163
344 METASTASES TO LIVER 163
345 NEUROTOXICITY 163
346 TOXIC SKIN ERUPTION 163
347 UVEITIS 163
348 PERICARDITIS 162
349 RADIATION PNEUMONITIS 162
350 NEOPLASM MALIGNANT 161
351 URINARY RETENTION 160
352 ANAPHYLACTIC SHOCK 159
353 BRAIN OEDEMA 159
354 PULMONARY FIBROSIS 159
355 ISCHAEMIC STROKE 157
356 MENINGITIS 157
357 RED BLOOD CELL COUNT DECREASED 157
358 SKIN ULCER 157
359 AUTOIMMUNE COLITIS 156
360 HYPOGLYCAEMIA 156
361 IMMUNE-MEDIATED HYPERTHYROIDISM 156
362 INFLUENZA 156
363 METASTASES TO LUNG 156
364 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 154
365 HEPATITIS CHOLESTATIC 154
366 BLOOD POTASSIUM DECREASED 153
367 CANCER PAIN 153
368 FULMINANT TYPE 1 DIABETES MELLITUS 153
369 GASTRIC ULCER 153
370 IMMUNE-MEDIATED MYASTHENIA GRAVIS 153
371 SHOCK 153
372 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 152
373 DYSARTHRIA 152
374 POLYARTHRITIS 152
375 SLEEP DISORDER 151
376 HYDRONEPHROSIS 150
377 IMMUNE-MEDIATED CHOLANGITIS 150
378 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 150
379 NECK PAIN 150
380 CHRONIC KIDNEY DISEASE 149
381 EPILEPSY 149
382 BLOOD LACTATE DEHYDROGENASE INCREASED 148
383 GASTROOESOPHAGEAL REFLUX DISEASE 148
384 IMPAIRED HEALING 148
385 NERVOUS SYSTEM DISORDER 148
386 AUTOIMMUNE THYROIDITIS 147
387 RECTAL HAEMORRHAGE 147
388 TUMOUR HAEMORRHAGE 147
389 CARDIAC FAILURE CONGESTIVE 146
390 MENINGITIS ASEPTIC 146
391 RASH PAPULAR 146
392 AMYLASE INCREASED 145
393 PERITONITIS 145
394 ATRIOVENTRICULAR BLOCK COMPLETE 144
395 BLOOD THYROID STIMULATING HORMONE DECREASED 144
396 SKIN LESION 142
397 ELECTROLYTE IMBALANCE 141
398 UNDERDOSE 141
399 METABOLIC ACIDOSIS 140
400 MIXED LIVER INJURY 140
401 MUSCULOSKELETAL STIFFNESS 140
402 RASH MACULAR 140
403 DEPRESSED LEVEL OF CONSCIOUSNESS 139
404 PRODUCT PRESCRIBING ISSUE 138
405 THERAPEUTIC RESPONSE UNEXPECTED 138
406 ADRENOCORTICAL INSUFFICIENCY ACUTE 137
407 METASTATIC MALIGNANT MELANOMA 137
408 MOBILITY DECREASED 137
409 INFLUENZA LIKE ILLNESS 136
410 NEPHROTIC SYNDROME 136
411 THERAPY CESSATION 136
412 VASCULITIS 136
413 HYPERBILIRUBINAEMIA 135
414 HYPOALBUMINAEMIA 135
415 LIVER FUNCTION TEST ABNORMAL 134
416 EATING DISORDER 133
417 TYPE 2 DIABETES MELLITUS 133
418 ATELECTASIS 132
419 CARDIAC TAMPONADE 132
420 IMMUNE SYSTEM DISORDER 131
421 AUTOIMMUNE DISORDER 130
422 RECURRENT CANCER 130
423 HOT FLUSH 129
424 MELAENA 129
425 SMALL INTESTINAL PERFORATION 129
426 RHINORRHOEA 128
427 FLATULENCE 126
428 GENERALISED OEDEMA 126
429 LIPASE INCREASED 126
430 MYASTHENIC SYNDROME 126
431 SKIN DISCOLOURATION 126
432 BLOOD UREA INCREASED 125
433 CYSTITIS 125
434 LUNG NEOPLASM MALIGNANT 125
435 MOUTH ULCERATION 125
436 FEELING COLD 124
437 PERIPHERAL SENSORY NEUROPATHY 124
438 RESPIRATORY TRACT INFECTION 124
439 AUTOIMMUNE HAEMOLYTIC ANAEMIA 123
440 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 123
441 MYOPATHY 123
442 GASTROINTESTINAL TOXICITY 122
443 SMALL INTESTINAL OBSTRUCTION 122
444 FEMALE GENITAL TRACT FISTULA 121
445 HAEMOLYTIC ANAEMIA 121
446 LEUKOCYTOSIS 121
447 TUMOUR HYPERPROGRESSION 121
448 ACUTE MYELOID LEUKAEMIA 120
449 DYSSTASIA 120
450 APHASIA 118
451 DEPRESSED MOOD 118
452 CANDIDA INFECTION 117
453 CARDIAC FAILURE ACUTE 117
454 IMMUNE-MEDIATED PNEUMONITIS 117
455 LUNG OPACITY 117
456 LYMPHOPENIA 117
457 BLOOD MAGNESIUM DECREASED 116
458 CHOLECYSTITIS ACUTE 116
459 DUODENAL ULCER 116
460 ENCEPHALITIS AUTOIMMUNE 116
461 MALIGNANT PLEURAL EFFUSION 116
462 SUDDEN DEATH 116
463 IMMUNE-MEDIATED GASTRITIS 115
464 TRANSIENT ISCHAEMIC ATTACK 115
465 LYMPHOCYTE COUNT DECREASED 114
466 POLLAKIURIA 114
467 SWELLING FACE 113
468 GLUCOCORTICOID DEFICIENCY 112
469 MALIGNANT MELANOMA 112
470 BLOOD ALBUMIN DECREASED 111
471 LICHEN PLANUS 110
472 SINUSITIS 110
473 BRADYCARDIA 109
474 LABORATORY TEST ABNORMAL 109
475 NON-SMALL CELL LUNG CANCER 109
476 THROMBOTIC MICROANGIOPATHY 109
477 ACUTE CORONARY SYNDROME 108
478 AMNESIA 108
479 CACHEXIA 108
480 DEVICE RELATED INFECTION 108
481 FACIAL PARALYSIS 108
482 VERTIGO 108
483 CLOSTRIDIUM DIFFICILE INFECTION 107
484 HAEMOGLOBIN ABNORMAL 107
485 MALNUTRITION 107
486 MENTAL STATUS CHANGES 107
487 OPTIC NEURITIS 107
488 VENTRICULAR TACHYCARDIA 107
489 CONTUSION 105
490 INTENTIONAL PRODUCT USE ISSUE 105
491 KETOACIDOSIS 105
492 STRESS CARDIOMYOPATHY 105
493 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 105
494 THIRST 105
495 DUODENITIS 104
496 FACE OEDEMA 104
497 MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS OVERLAP SYNDROME 104
498 DEMENTIA 103
499 ELECTROCARDIOGRAM QT PROLONGED 103
500 NEURALGIA 103
501 PURPURA 103
502 THYROID FUNCTION TEST ABNORMAL 103
503 CARDIAC DYSFUNCTION 102
504 GLOSSODYNIA 102
505 OSTEONECROSIS OF JAW 102
506 DIABETES MELLITUS INADEQUATE CONTROL 101
507 DISORIENTATION 100
508 ORAL CANDIDIASIS 100
509 COLITIS MICROSCOPIC 99
510 LACRIMATION INCREASED 99
511 CLOSTRIDIUM DIFFICILE COLITIS 97
512 DRUG DOSE OMISSION 97
513 HYPERTHERMIA 97
514 CYTOMEGALOVIRUS INFECTION 96
515 DIVERTICULITIS 96
516 HAEMATEMESIS 96
517 BLINDNESS 95
518 BLOOD CORTICOTROPHIN DECREASED 95
519 BLOOD PRESSURE SYSTOLIC INCREASED 95
520 INCORRECT PRODUCT ADMINISTRATION DURATION 95
521 STAPHYLOCOCCAL INFECTION 95
522 BRAIN FOG 94
523 EMBOLISM 94
524 EMPHYSEMA 92
525 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 92
526 HALLUCINATION 91
527 HEPATITIS ACUTE 91
528 PROTEIN URINE PRESENT 91
529 SARCOIDOSIS 91
530 CATARACT 90
531 CONJUNCTIVITIS 90
532 DISTURBANCE IN ATTENTION 90
533 HAEMATOCRIT DECREASED 90
534 HEPATIC ENCEPHALOPATHY 90
535 PRODUCT DOSE OMISSION 90
536 APHONIA 89
537 CHOLELITHIASIS 89
538 HEPATIC STEATOSIS 89
539 ANGINA PECTORIS 88
540 TRANSFUSION 88
541 URINARY INCONTINENCE 88
542 FUNGAL INFECTION 87
543 NEUTROPENIC SEPSIS 87
544 PHYSICAL DECONDITIONING 87
545 ASTHMA 86
546 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 86
547 FISTULA 86
548 HEART RATE DECREASED 86
549 UPPER GASTROINTESTINAL HAEMORRHAGE 86
550 ANGIOEDEMA 85
551 EOSINOPHIL COUNT INCREASED 85
552 HYPERSOMNIA 85
553 TUMOUR ASSOCIATED FEVER 85
554 AUTOIMMUNE HYPOTHYROIDISM 84
555 BACTERAEMIA 84
556 HEMIPARESIS 84
557 VASCULAR ACCESS COMPLICATION 84
558 DISCOMFORT 83
559 LOWER RESPIRATORY TRACT INFECTION 83
560 PALLOR 83
561 PHOTOSENSITIVITY REACTION 83
562 ADVERSE REACTION 82
563 AGITATION 82
564 GASTROENTERITIS 82
565 LUNG ADENOCARCINOMA 82
566 RASH VESICULAR 82
567 ARTHROPATHY 81
568 NASAL CONGESTION 81
569 OVERDOSE 81
570 WHEEZING 81
571 CENTRAL VENOUS CATHETERISATION 80
572 IMMUNE-MEDIATED NEUROPATHY 80
573 LUNG INFILTRATION 80
574 VAGINAL HAEMORRHAGE 80
575 BACTERIAL INFECTION 79
576 BLOOD CALCIUM DECREASED 79
577 BLOOD GLUCOSE ABNORMAL 79
578 BURNING SENSATION 79
579 COMA 79
580 LYMPHANGIOSIS CARCINOMATOSA 79
581 POOR QUALITY SLEEP 79
582 DEAFNESS 78
583 DISEASE RECURRENCE 78
584 RESPIRATORY DISORDER 78
585 THERAPY INTERRUPTED 78
586 TUMOUR NECROSIS 78
587 BLOOD TEST ABNORMAL 77
588 CIRCULATORY COLLAPSE 77
589 FEELING HOT 77
590 HYPERTENSIVE CRISIS 77
591 IMMUNE-MEDIATED ENDOCRINOPATHY 77
592 NIGHT SWEATS 77
593 SINUS TACHYCARDIA 77
594 WEIGHT FLUCTUATION 77
595 ABDOMINAL PAIN LOWER 76
596 SECOND PRIMARY MALIGNANCY 76
597 SYSTEMIC LUPUS ERYTHEMATOSUS 76
598 HEPATIC CIRRHOSIS 75
599 METASTASES TO LYMPH NODES 75
600 ARTERIOSCLEROSIS 74
601 ASPIRATION 74
602 BLOOD THYROID STIMULATING HORMONE ABNORMAL 74
603 BRONCHITIS 74
604 CORONARY ARTERY DISEASE 74
605 JOINT STIFFNESS 74
606 LIVER ABSCESS 74
607 MUSCULOSKELETAL CHEST PAIN 74
608 TROPONIN I INCREASED 74
609 INSURANCE ISSUE 73
610 MALIGNANT NEOPLASM OLIGOPROGRESSION 73
611 MENTAL DISORDER 73
612 TINNITUS 73
613 COVID-19 PNEUMONIA 72
614 DERMATITIS PSORIASIFORM 72
615 ENDOCRINE DISORDER 72
616 EYE DISORDER 72
617 LYMPHOEDEMA 72
618 PLATELET COUNT ABNORMAL 72
619 RASH GENERALISED 72
620 UPPER RESPIRATORY TRACT INFECTION 72
621 BICYTOPENIA 71
622 BLOOD POTASSIUM INCREASED 71
623 INFLAMMATORY MARKER INCREASED 71
624 MUSCLE ATROPHY 71
625 PSORIATIC ARTHROPATHY 71
626 SUSPECTED OFF LABEL USE 71
627 FLANK PAIN 70
628 LYMPHADENECTOMY 70
629 MIGRAINE 70
630 PERFORMANCE STATUS DECREASED 70
631 UNRESPONSIVE TO STIMULI 70
632 ACUTE HEPATIC FAILURE 69
633 CORONAVIRUS INFECTION 69
634 DECREASED ACTIVITY 69
635 EYE PAIN 69
636 HICCUPS 69
637 THERAPEUTIC RESPONSE DECREASED 69
638 VISUAL ACUITY REDUCED 69
639 ATAXIA 68
640 CAPILLARY LEAK SYNDROME 68
641 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 68
642 FAECES DISCOLOURED 68
643 LEFT VENTRICULAR DYSFUNCTION 68
644 NEUTROPHIL COUNT INCREASED 68
645 SUBARACHNOID HAEMORRHAGE 68
646 THROMBOPHLEBITIS MIGRANS 68
647 THYROID HORMONES INCREASED 68
648 APLASIA PURE RED CELL 67
649 FULL BLOOD COUNT DECREASED 67
650 NECROSIS 67
651 NEOPLASM 67
652 CHROMATURIA 66
653 NODULE 66
654 SHOCK HAEMORRHAGIC 66
655 UROGENITAL FISTULA 66
656 BRAIN NATRIURETIC PEPTIDE INCREASED 65
657 LYMPHADENOPATHY MEDIASTINAL 65
658 SCAB 65
659 WHITE BLOOD CELL COUNT ABNORMAL 65
660 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 64
661 BLOOD URINE PRESENT 64
662 HYPERPYREXIA 64
663 INFUSION SITE EXTRAVASATION 64
664 LIP SWELLING 64
665 OSTEOARTHRITIS 64
666 PRESYNCOPE 64
667 RENAL TUBULAR DISORDER 64
668 STRESS 64
669 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 64
670 ADDISON^S DISEASE 63
671 AUTOIMMUNE PANCREATITIS 63
672 DERMATOMYOSITIS 63
673 GINGIVAL BLEEDING 63
674 HAEMORRHOIDS 63
675 HEPATITIS FULMINANT 63
676 HEPATITIS TOXIC 63
677 METASTASES TO MENINGES 63
678 ORAL DISCOMFORT 63
679 SKIN EROSION 63
680 UROSEPSIS 63
681 BLOOD CREATININE ABNORMAL 62
682 BLOOD GLUCOSE DECREASED 62
683 BODY TEMPERATURE INCREASED 62
684 CARCINOEMBRYONIC ANTIGEN INCREASED 62
685 DUODENAL PERFORATION 62
686 FEAR 62
687 SPINAL COMPRESSION FRACTURE 62
688 FLUID RETENTION 61
689 HYPERTRIGLYCERIDAEMIA 61
690 HYPOACUSIS 61
691 INABILITY TO AFFORD MEDICATION 61
692 METASTASIS 61
693 OSTEOPOROSIS 61
694 PARALYSIS 61
695 PSEUDOCELLULITIS 61
696 TUMOUR MARKER INCREASED 61
697 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 61
698 ACNE 60
699 APPETITE DISORDER 60
700 DERMATITIS EXFOLIATIVE GENERALISED 60
701 ERYSIPELAS 60
702 GASTRIC PERFORATION 60
703 MYELODYSPLASTIC SYNDROME 60
704 PAPILLOEDEMA 60
705 ASPARTATE AMINOTRANSFERASE ABNORMAL 59
706 COLITIS ISCHAEMIC 59
707 FAILURE TO THRIVE 59
708 GROIN PAIN 59
709 MASTECTOMY 59
710 NEUTROPHIL COUNT ABNORMAL 59
711 PANCREATIC DISORDER 59
712 BRONCHOPULMONARY ASPERGILLOSIS 58
713 DIARRHOEA HAEMORRHAGIC 58
714 ENDOCARDITIS 58
715 IMMUNE THROMBOCYTOPENIC PURPURA 58
716 LIMB DISCOMFORT 58
717 OCULAR HYPERAEMIA 58
718 OSTEOMYELITIS 58
719 PLEURISY 58
720 RENAL INJURY 58
721 SWOLLEN TONGUE 58
722 THYROID HORMONES DECREASED 58
723 CHEMOTHERAPY 57
724 FRACTURE 57
725 FREQUENT BOWEL MOVEMENTS 57
726 HYPERSENSITIVITY PNEUMONITIS 57
727 ORAL DISORDER 57
728 PAIN OF SKIN 57
729 PARANEOPLASTIC SYNDROME 57
730 REBOUND EFFECT 57
731 RETINAL DETACHMENT 57
732 VENTRICULAR EXTRASYSTOLES 57
733 VIRAL INFECTION 57
734 ALANINE AMINOTRANSFERASE ABNORMAL 56
735 LYMPHOMA 56
736 MELANOMA RECURRENT 56
737 MUSCULOSKELETAL DISORDER 56
738 SPINAL OSTEOARTHRITIS 56
739 SUPRAVENTRICULAR TACHYCARDIA 56
740 WOUND 56
741 ARTERIOSCLEROSIS CORONARY ARTERY 55
742 CARBOHYDRATE ANTIGEN 125 INCREASED 55
743 CHRONIC GASTRITIS 55
744 DERMATITIS ALLERGIC 55
745 DIASTOLIC DYSFUNCTION 55
746 KERATITIS 55
747 LUNG CONSOLIDATION 55
748 NEPHRECTOMY 55
749 NEUROLOGICAL SYMPTOM 55
750 PATHOLOGICAL FRACTURE 55
751 PROTEIN TOTAL DECREASED 55
752 SKIN BURNING SENSATION 55
753 TRANSITIONAL CELL CARCINOMA METASTATIC 55
754 APLASTIC ANAEMIA 54
755 AUTOIMMUNE MYOCARDITIS 54
756 CHOLESTATIC LIVER INJURY 54
757 COAGULOPATHY 54
758 CYTOKINE STORM 54
759 GASTROINTESTINAL INFLAMMATION 54
760 LUMBAR VERTEBRAL FRACTURE 54
761 PRIMARY ADRENAL INSUFFICIENCY 54
762 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 54
763 SQUAMOUS CELL CARCINOMA OF SKIN 54
764 CHEILITIS 53
765 HAEMORRHAGE INTRACRANIAL 53
766 INFECTIOUS PLEURAL EFFUSION 53
767 MOTOR DYSFUNCTION 53
768 ORTHOSTATIC HYPOTENSION 53
769 PANCREATIC FAILURE 53
770 RASH MORBILLIFORM 53
771 RESTLESSNESS 53
772 THROAT IRRITATION 53
773 AUTOIMMUNE NEPHRITIS 52
774 GLYCOSYLATED HAEMOGLOBIN INCREASED 52
775 HYPERKERATOSIS 52
776 HYPERURICAEMIA 52
777 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 52
778 PNEUMATOSIS INTESTINALIS 52
779 PRERENAL FAILURE 52
780 SKIN IRRITATION 52
781 SPINAL FRACTURE 52
782 C-REACTIVE PROTEIN ABNORMAL 51
783 CARPAL TUNNEL SYNDROME 51
784 IMMUNE-MEDIATED UVEITIS 51
785 INTESTINAL ISCHAEMIA 51
786 KL-6 INCREASED 51
787 LIMB INJURY 51
788 MYOCARDIAL ISCHAEMIA 51
789 NEOPLASM RECURRENCE 51
790 NEPHROLITHIASIS 51
791 PULMONARY HAEMORRHAGE 51
792 THYROTOXIC CRISIS 51
793 TOOTH DISORDER 51
794 ACQUIRED GENE MUTATION 50
795 GOUT 50
796 PLATELET COUNT INCREASED 50
797 PULMONARY SARCOIDOSIS 50
798 SKIN INFECTION 50
799 STAPHYLOCOCCAL BACTERAEMIA 50
800 APPENDICITIS 49
801 ATRIAL FLUTTER 49
802 BREAST CANCER RECURRENT 49
803 DECUBITUS ULCER 49
804 FAECES SOFT 49
805 GENERALISED TONIC-CLONIC SEIZURE 49
806 GINGIVITIS 49
807 HEPATIC ENZYME ABNORMAL 49
808 HEPATIC LESION 49
809 IMMUNODEFICIENCY 49
810 JAUNDICE CHOLESTATIC 49
811 LUNG INFECTION 49
812 MYOCARDIAL INJURY 49
813 OXYGEN THERAPY 49
814 PSEUDOMONAS INFECTION 49
815 RADIATION NECROSIS 49
816 RENAL FUNCTION TEST ABNORMAL 49
817 SCLERODERMA 49
818 TROPONIN T INCREASED 49
819 TUBERCULOSIS 49
820 TUMOUR PAIN 49
821 ATRIOVENTRICULAR BLOCK 48
822 BLOOD CHLORIDE DECREASED 48
823 BLOOD CREATINE INCREASED 48
824 CANCER SURGERY 48
825 EOSINOPHILIC FASCIITIS 48
826 HAEMOLYSIS 48
827 IMMUNE-MEDIATED NEUROLOGICAL DISORDER 48
828 SARS-COV-2 TEST POSITIVE 48
829 ANGER 47
830 CELL DEATH 47
831 DERMATITIS ACNEIFORM 47
832 GENERAL PHYSICAL CONDITION ABNORMAL 47
833 GLOSSITIS 47
834 NAIL DISORDER 47
835 PIGMENTATION DISORDER 47
836 PULMONARY TUBERCULOSIS 47
837 RENAL CYST 47
838 SILENT THYROIDITIS 47
839 ABSCESS 46
840 AORTIC ARTERIOSCLEROSIS 46
841 AORTIC DISSECTION 46
842 CARDIOVASCULAR DISORDER 46
843 CEREBRAL ISCHAEMIA 46
844 FIBRIN D DIMER INCREASED 46
845 GASTRIC DISORDER 46
846 GASTRIC HAEMORRHAGE 46
847 IMMUNE-MEDIATED CYSTITIS 46
848 LARYNGEAL OEDEMA 46
849 PAIN IN JAW 46
850 PERIPHERAL ISCHAEMIA 46
851 RENAL TUBULAR INJURY 46
852 RHEUMATIC DISORDER 46
853 TRANSPLANT REJECTION 46
854 TREATMENT NONCOMPLIANCE 46
855 UNEVALUABLE EVENT 46
856 ACIDOSIS 45
857 BILIARY OBSTRUCTION 45
858 BLOOD CALCIUM INCREASED 45
859 CENTRAL NERVOUS SYSTEM LESION 45
860 GASTROINTESTINAL MOTILITY DISORDER 45
861 GINGIVAL PAIN 45
862 IRIDOCYCLITIS 45
863 ISCHAEMIA 45
864 LUNG ABSCESS 45
865 MALIGNANT ASCITES 45
866 OPHTHALMOPLEGIA 45
867 ORAL HERPES 45
868 SQUAMOUS CELL CARCINOMA 45
869 ABNORMAL LOSS OF WEIGHT 44
870 BLOOD CHOLESTEROL INCREASED 44
871 EXTREMITY NECROSIS 44
872 HEAD INJURY 44
873 MASS 44
874 RETCHING 44
875 SIALOADENITIS 44
876 SPINAL PAIN 44
877 SUBDURAL HAEMATOMA 44
878 TOOTHACHE 44
879 ULCER 44
880 VENOUS THROMBOSIS 44
881 COLON CANCER 43
882 FEMUR FRACTURE 43
883 FRUSTRATION TOLERANCE DECREASED 43
884 HYPOVOLAEMIC SHOCK 43
885 IRRITABILITY 43
886 MATERNAL EXPOSURE DURING PREGNANCY 43
887 MOUTH HAEMORRHAGE 43
888 MYELITIS TRANSVERSE 43
889 PETECHIAE 43
890 POST PROCEDURAL COMPLICATION 43
891 PULMONARY ALVEOLAR HAEMORRHAGE 43
892 AUTOIMMUNE LUNG DISEASE 42
893 BLOOD DISORDER 42
894 CERVIX CARCINOMA RECURRENT 42
895 EMBOLISM VENOUS 42
896 GLOMERULAR FILTRATION RATE DECREASED 42
897 INTENTIONAL PRODUCT MISUSE 42
898 POLYURIA 42
899 PULSE ABNORMAL 42
900 SARCOID-LIKE REACTION 42
901 SYSTEMIC CANDIDA 42
902 ADENOCARCINOMA 41
903 BLOOD POTASSIUM ABNORMAL 41
904 BONE LESION 41
905 BRONCHIECTASIS 41
906 CYANOSIS 41
907 EYE SWELLING 41
908 MENTAL IMPAIRMENT 41
909 MUSCLE DISORDER 41
910 NEPHROPATHY 41
911 PLASMA CELL MYELOMA 41
912 PRODUCT AVAILABILITY ISSUE 41
913 PULMONARY CONGESTION 41
914 PULMONARY HYPERTENSION 41
915 QUALITY OF LIFE DECREASED 41
916 RAYNAUD^S PHENOMENON 41
917 RIB FRACTURE 41
918 VANISHING BILE DUCT SYNDROME 41
919 VASCULAR DEVICE INFECTION 41
920 BLOOD CORTICOTROPHIN INCREASED 40
921 BLOOD PRESSURE DIASTOLIC INCREASED 40
922 GASTROINTESTINAL NECROSIS 40
923 HYPOPHOSPHATAEMIA 40
924 HYPOTHERMIA 40
925 METASTASES TO PERITONEUM 40
926 NERVOUSNESS 40
927 PAPULE 40
928 PHOTOPHOBIA 40
929 PROCEDURAL PAIN 40
930 RED CELL DISTRIBUTION WIDTH INCREASED 40
931 STAPHYLOCOCCAL SEPSIS 40
932 TACHYPNOEA 40
933 ACCIDENTAL EXPOSURE TO PRODUCT 39
934 IMMUNOTOXICITY 39
935 INCONTINENCE 39
936 INCREASED APPETITE 39
937 KIDNEY INFECTION 39
938 NAIL DISCOLOURATION 39
939 OSTEONECROSIS 39
940 PERIPHERAL MOTOR NEUROPATHY 39
941 POLYMYOSITIS 39
942 POOR VENOUS ACCESS 39
943 THERAPEUTIC PRODUCT EFFECT DECREASED 39
944 ASPHYXIA 38
945 AUTOIMMUNE ARTHRITIS 38
946 AZOTAEMIA 38
947 BLOOD TRIGLYCERIDES INCREASED 38
948 CARDIOMEGALY 38
949 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 38
950 COMPRESSION FRACTURE 38
951 DIABETES INSIPIDUS 38
952 EOSINOPHILIC PNEUMONIA 38
953 GRANULOMA 38
954 HAEMATOMA 38
955 HIP FRACTURE 38
956 IMMUNOSUPPRESSION 38
957 LOCALISED INFECTION 38
958 LOWER GASTROINTESTINAL HAEMORRHAGE 38
959 LUPUS-LIKE SYNDROME 38
960 LYMPHOCYTIC HYPOPHYSITIS 38
961 MUSCULOSKELETAL DISCOMFORT 38
962 MYASTHENIA GRAVIS CRISIS 38
963 NASAL DRYNESS 38
964 ODYNOPHAGIA 38
965 PARONYCHIA 38
966 PRODUCT PRESCRIBING ERROR 38
967 THROMBOTIC THROMBOCYTOPENIC PURPURA 38
968 VITREOUS FLOATERS 38
969 ABDOMINAL ABSCESS 37
970 ABNORMAL FAECES 37
971 AORTITIS 37
972 BRAIN NEOPLASM 37
973 BREAST CANCER 37
974 DYSAESTHESIA 37
975 EAR PAIN 37
976 GALLBLADDER DISORDER 37
977 HENOCH-SCHONLEIN PURPURA 37
978 IMMUNE-MEDIATED OESOPHAGITIS 37
979 IMMUNE-MEDIATED PANCYTOPENIA 37
980 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 37
981 LIP OEDEMA 37
982 MYOCARDIAL NECROSIS MARKER INCREASED 37
983 PROCALCITONIN INCREASED 37
984 PROCTALGIA 37
985 PYODERMA GANGRENOSUM 37
986 SMALL INTESTINAL HAEMORRHAGE 37
987 STATUS EPILEPTICUS 37
988 TONGUE DISCOMFORT 37
989 VENTRICULAR FIBRILLATION 37
990 ADRENALITIS 36
991 BEDRIDDEN 36
992 BLOOD LACTATE DEHYDROGENASE ABNORMAL 36
993 CEREBRAL DISORDER 36
994 CUTANEOUS VASCULITIS 36
995 GALLBLADDER ENLARGEMENT 36
996 GASTRITIS HAEMORRHAGIC 36
997 GLOMERULONEPHRITIS 36
998 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 36
999 HEPATOMEGALY 36